In this open study, the efficacy of ointment and universal cream(w/o type) containing 0.1% diflucortolone 21-valerate (DFV), a derivative of corticosteroid without OH group at the posi-tion of 17
α, was investigated by a collaborative group of dermatologists from 30 institutions in Japan. Analyses were done on 578 cases and the following results were obtained.
1) A half side test was carried out in patients with oozing type of eczematous dermatitis, lichenified type of eczematous dermatitis, psoriasis vulgaris, pustulosis palmaris et plantaris and hand eczema, using 0.12 % betamethasone valerate (BTV) ointment as a control drug. DFV ointment of 0.1 % showed superiority to BTV ointment in the drug preference in oozing type of eczematous dermatitis, in the drug preference and general improvement in psoriasis vulgaris, as well as in the comparison of global usefulness in all cases. No significant difference was observed in lichenified eczematous dermatitis. Double blind trials are now in progress.
2) Furthermore, clinical effects were investigated with ointment and universal cream of DFV in hand eczema, seborrheic dermatitis, various types of prurigo, exfoliative dermatitis, chronic discoid lupus erythematosus, lichen amyloidosus, lichen planus, etc. Results showed a pretty good effect on skin lesions and a high global usefulness of the drugs.
3) Topical adverse reactions were noticed in 4 % of the cases.
View full abstract